Oral Anticoagulation with Factor Xa and Direct Thrombin Inhibitors across the Arterial-Venous Thrombosis Risk Continuum: Epidemiology, Shared Risk Factors, and Pathophysiology of VTE and Stroke in the Setting of Atrial Fibrillation - Samuel Z. Goldhaber, MD – Program Co-Chairman